Another drug, Glyburide, has been shown to produce potentially adverse side effects on neutrophil and monocyte-mediated immune responses against Mtb (reducing IL-1β and IL-8 production) thereby exacerbating susceptibility of diabetes patients to Mtb infection [36]. Here, IL1B is linked to diabetes mellitus.